Board Meeting4 Aug 2026, 06:20 pm
Sudeep Pharma Declares Q1 FY27 Unaudited Financial Results
AI Summary
Sudeep Pharma Limited announced the outcome of its Board Meeting held on August 4, 2026. The Board considered and approved the Unaudited Standalone & Consolidated Financial Results for the first quarter ended June 30, 2026. The meeting commenced at 3:40 p.m. and concluded at 5:50 p.m. The limited review report on the consolidated financial results for the quarter ended June 30, 2026, was also presented. The results include financial data from two subsidiaries, which had a combined revenue of ₹1,139.55 lakhs and a net loss after tax of ₹49.12 lakhs before consolidation adjustments.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Results are for standalone and consolidated financial statements.
- Meeting held on August 4, 2026.
- Includes financial data from two subsidiaries.
- Limited review report was presented.
Price Impact
More from SUDEEPPHRM